| 000 | 01840 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515074105.0 | ||
| 264 | 0 | _c20071109 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1059-1524 | ||
| 024 | 7 |
_a10.1091/mbc.e07-01-0035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEisele, Yvonne S | |
| 245 | 0 | 0 |
_aGleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin. _h[electronic resource] |
| 260 |
_bMolecular biology of the cell _cSep 2007 |
||
| 300 |
_a3591-600 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmmonium Chloride _xpharmacology |
| 650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xchemistry |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNeprilysin _xgenetics |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aBaumann, Matthias | |
| 700 | 1 | _aKlebl, Bert | |
| 700 | 1 | _aNordhammer, Christina | |
| 700 | 1 | _aJucker, Mathias | |
| 700 | 1 | _aKilger, Ellen | |
| 773 | 0 |
_tMolecular biology of the cell _gvol. 18 _gno. 9 _gp. 3591-600 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1091/mbc.e07-01-0035 _zAvailable from publisher's website |
| 999 |
_c17161219 _d17161219 |
||